Australian vaccine set for overseas test

The effectiveness of a University of Queensland vaccine for coronavirus is about to be tested in a biosecurity facility in the Netherlands.

The vaccine will be used on live coronavirus for the first time to determine how effectively it induces protection against infection.

UQ's vaccine program co-leader Dr Keith Chappell said the trial will establish a critical package of data ahead of human clinical trials later this year. Clinical studies will be conducted by Viroclinics Xplore which offers a myriad of preclinical tests including toxicology of drugs, antibodies, and antivirals targeting viral infectious diseases.

 

UQ created COVID-19 in its laboratory and then set about designing a vaccine to combat the virus.

The vaccine locks the "spike" protein into a shape which allows the immune system to be able to recognise and neutralise it.

UQ's Professor Trent Munro said beginning a large multi-arm study at Viroclinics Xplore was critical, before human testing, because it would establish a more comprehensive understanding of how the vaccine performs.

Originally published as UQ coronavirus vaccine set for overseas test



Witness came to woman’s rescue during alleged sex attack

Premium Content Witness came to woman’s rescue during alleged sex attack

The alleged attack happened in a public bathroom in Maryborough

Court hears disturbing details of alleged toilet sex attack

Premium Content Court hears disturbing details of alleged toilet sex attack

The man allegedly told the woman to tell police she was his girlfriend

Facial recognition to access welfare in overhaul

Premium Content Facial recognition to access welfare in overhaul

Australians will be able to use facial recognition to access welfare through...